Pulse Biosciences, Inc.
PLSE
Pozycja w akcjach
#4273
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Cena akcji
$51.39
Ostatnia synchronizacja: 2026-10-21
Kapitalizacja rynkowa
$3.67B
Zmiana (1 dzień)
1.09%
Zmiana (1 rok)
197.94%
Kraj
US
Handel Pulse Biosciences, Inc. (PLSE)
Kategoria
Healthcare
Historia stopy dywidendy dla Pulse Biosciences, Inc. (PLSE)
Stopa dywidendy (TTM) dla Pulse Biosciences, Inc. (symbol akcji: PLSE) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Pulse Biosciences, Inc. (PLSE) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
| Rok | Stopa dywidendy | Zmień |
|---|---|---|
| Za mało danych dla podanych dat. | ||
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
| Firma | Stopa dywidendy | Kraj |
|---|---|---|
| 0.00% |
US
|
|
| 2.70% |
FR
|
|
| 0.00% |
JP
|
|
| 2.10% |
US
|
|
| 0.00% |
CH
|
